ReviewCurrent atherosclerosis reports2026
From Inflammation to Targeted Therapy: Leveraging Neutrophil, Platelet, RBC, and Macrophage Biology for Nanocarrier in Atherosclerosis.
Farshad Heydari et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it